Illumina INC:1107104 [20-003190] - to prepare libraries for next-generation sequencing of 1056 patient samples with systemic lupus erythematosus (SLE) to prepare libraries for next-generation…
Ended Awarded
- Contract number
- 75N92B20F20001
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $107,884
Award facts
- Contract value 100% obligated
- $107,884.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$32 | |
| Original award | $107,916 |
About this award
This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $107,884.35 contract is for Illumina to prepare libraries for next-generation sequencing of 1,056 patient samples with systemic lupus erythematosus. The work will be performed in San Diego, California. The contract does not have a set-aside designation and the completion date is September 2, 2025. Illumina has a history of federal contract awards, including with agencies like the NIH, CDC, USDA, and VA, for providing genomic sequencing systems, consumables, and bioinformatics support for research and diagnostics applications.
Description
Illumina INC:1107104 [20-003190] - to prepare libraries for next-generation sequencing of 1056 patient samples with systemic lupus erythematosus (SLE) to prepare libraries for next-generation sequencing of 1056 patient samples with systemic lupus ER
Quick answers
Who was awarded contract 75N92B20F20001?
75N92B20F20001 was awarded to Illumina, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 18, 2020.
How much is contract 75N92B20F20001 worth?
The government has obligated $107,884 on 75N92B20F20001.
Is contract 75N92B20F20001 an order under another contract?
Yes. 75N92B20F20001 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N92B20F20001 competed?
The extent of competition for 75N92B20F20001 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award